EP3485890
SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.1.2015:
10.5.2023:
18208143.0
:
19.1.2035
:
SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
20.1.2015
10.5.2023
:
Boehringer Ingelheim Vetmedica GmbH:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
:
REICHE, Dania Birte:
55216 INGELHEIM AM RHEIN, DE
:
KLEY, Saskia:
55216 INGELHEIM AM RHEIN, DE
:
14152327:
23.1.2014:
EP
:
14186477:
25.9.2014:
EP
:
A61K 31/7034, A61P 3/06, A61P 3/10, A61K 9/02, A61K 9/08, A61K 9/20, A61K 9/48, A61K 38/28, A61K 45/06, A61K 31/00, A61P 1/16, A61P 1/18, A61P 13/12, A61P 19/00, A61P 21/00, A61P 27/02, A61P 27/12, A61P 29/00, A61P 3/00